Market Cap: $2.2B
VC
Vericel Corporation
VCEL
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $2.2B
Vericel Corporation Achieves Milestones in Q4 Earnings Report Vericel Corporation (NASDAQ:VCEL) demonstrates a positive trajectory in its fourth-quarter earnings report, released on February 26, 2026.…
Vericel Corporation's Strong Q4 Earnings Highlight Commitment to Innovation and Market Expansion Vericel Corporation, a leader in the biotechnology sector, recently reported robust financial results f…
Vericel Showcases Growth and Strategic Advancements in Q4 Earnings Report Vericel Corporation reports a promising fourth quarter, showcasing marked growth across its product offerings and financial pe…
Vericel's Growth Potential in Regenerative Medicine Vericel Corporation, a notable player in the regenerative medicine sector, continues to leverage its innovative therapies to address unmet medical n…
Vericel's Innovations in Regenerative Medicine Signal Growth Potential Vericel, a leading player in the field of regenerative medicine, is making significant strides with its innovative cell-based the…
Vericel's Position in the Regenerative Medicine Landscape: A Focus on Cell-Based Therapies Vericel Corporation stands at the forefront of regenerative medicine, specializing in cell-based therapies fo…
Regenerative Medicine Market Poised for Robust Growth The regenerative medicine market is on the verge of significant expansion, projected to reach $37.27 billion by 2031, according to a new report fr…